Bumper Offer - Urjas oil Just @ Rs. 1
Olsertain AM Tablet (10) is a prescription drug, available for use as Tablet. The alternative uses of Olsertain AM Tablet (10) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Olsertain AM Tablet (10). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Olsertain AM Tablet (10) include Upper respiratory tract infection. Some other side effects of Olsertain AM Tablet (10) have been listed ahead. Such side effects of Olsertain AM Tablet (10) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Olsertain AM Tablet (10) has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Olsertain AM Tablet (10)'s effects on the liver, heart and kidney are discussed below in the Olsertain AM Tablet (10) related warnings section.
Olsertain AM Tablet (10) is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. Some other conditions that can be affected by Olsertain AM Tablet (10) are listed in the contraindications section below.
Besides this, Olsertain AM Tablet (10) may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Olsertain AM Tablet (10) is not safe while driving, and is is not addictive in nature.
Olsertain AM Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olsertain AM Tablet (10) is used -
Moderate
Mild
Is the use of Olsertain AM Tablet (10) safe for pregnant women?
Olsertain AM can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Olsertain AM Tablet (10) safe during breastfeeding?
Olsertain AM has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olsertain AM Tablet (10) on the Kidneys?
Olsertain AM may have mild side effects on the kidneys.
What is the effect of Olsertain AM Tablet (10) on the Liver?
Very few cases of side effects of Olsertain AM on the liver have been reported.
What is the effect of Olsertain AM Tablet (10) on the Heart?
Side effects of Olsertain AM rarely affect the heart.
Olsertain AM Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olsertain AM Tablet (10) unless your doctor advises you to do so -
Is this Olsertain AM Tablet (10) habit forming or addictive?
No, you will not get addicted to Olsertain AM Tablet (10).
Interaction between Food and Olsertain AM Tablet (10)
Some foods when eaten with Olsertain AM Tablet (10) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olsertain AM Tablet (10)
Consuming Olsertain AM Tablet (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
